3rd Quarter - Report — BOEHRINGER INGELHEIM USA CORPORATION, F… for BOEHRINGER INGELHEIM USA CORPORATION (2017)

Firm

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

Client

BOEHRINGER INGELHEIM USA CORPORATION

Income

—

Expenses

$200,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act. Resolution expressing support for the designation of November 9, 2017 as "National Diabetes Heart Connection Awareness Day."

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 469 (115th), S.Con.Res. 3 (115th)

Animals ANI

Veterinary Biologics, S. 1200 (Fairness to Pet Owners Act).

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 1200 (115th)

Consumer Issues/Safety/Products CSP

Prescription Drug User Fee reauthorization.

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Non-Interference; and Drug Pricing. HR. 849 Protecting Seniors' Access to Medicare Act of 2017 (IPAB) Medicare S. Con. Res. 3 - 2017 Budget President's 2018 Budget Blue Print

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 3 (115th), H.R. 849 (115th)

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; CMS Rule coding for Biosimilars; IPAB (Independent Payment Advisory Board). Biosimilars and the Part D Coverage Gap Discount.

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Accounting ACC

Importation - Affordable and Safe Prescription Drug Importation Act- Sanders

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.